SRTA
Strata Critical Medical, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +6.7% ·
share flow +12.6% ·
net new positions +6.2%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 16.12K | $72,070 | +1 | n/a |
| Q2 2026 | 64 | +2 | 30.62M | $161.23M | +5 | −4 |
| Q1 2026 | 65 | -1 | 35.82M | $149.75M | +2 | −3 |
| Q4 2025 | 66 | -2 | 36.14M | $173.84M | n/a | −2 |
| Q3 2025 | 16 | +1 | 24.58M | $124.36M | +2 | −1 |
| Q2 2025 | 12 | +1 | 20.26M | $81.63M | +1 | n/a |
| Q1 2025 | 8 | -1 | 12.11M | $33.06M | n/a | −1 |
| Q4 2024 | 9 | 0 | 12.82M | $54.49M | n/a | n/a |
| Q3 2024 | 8 | +1 | 9.76M | $28.71M | +1 | n/a |
| Q2 2024 | 7 | n/a | 8.74M | $30.43M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.40M | -25.5% | $32.41M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 2 | Third Point ✦ | 5.00M | New | $25.30M | 0.3% | New | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 4.32M | +0.9% | $21.86M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 4 | The Vanguard Group ✦ (passive) | 3.38M | +2.5% | $17.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (passive) | 1.61M | +3.5% | $8.13M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passive) | 1.31M | +1.0% | $6.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 791.16K | n/a | $4.00M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 8 | Renaissance Technologies ✦ | 598.39K | -15.9% | $3.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 518.28K | n/a | $2.62M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 10 | Goldman Sachs Group ✦ | 253.79K | n/a | $1.28M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 152.35K | +25.6% | $770,896 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 150.05K | -7.1% | $759,273 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 13 | Millennium Management ✦ | 34.50K | -37.9% | $174,555 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 34.08K | +13.1% | $173,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 20.22K | New | $102,298 | 0.0% | New | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 5.77K | -11.1% | $29,190 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Third Point | $25.30M | 0.3% |
| D. E. Shaw & Co. | $102,298 | 0.0% |
Exited
| Marshall Wace | $580,994 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 125 holders, 55.49M shares, $231.60M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 5.09K sh · $29,273
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
5.8% of class · View original SEC filing ↗